| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.10. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -3- | 3.833 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameKYG200801002 CBAK... ► Artikel lesen | |
| AESTHETIC MEDICAL INTERNATIONAL Aktie jetzt für 0€ handeln | |||||
| 11.08. | Aesthetic Medical International Holdings Group Ltd - 15-12G, Securities registration termination | - | SEC Filings | ||
| 21.05. | XFRA 3FMA,833: AUSSETZUNG/SUSPENSION | 433 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILAEST.MED.INT.HLD.SP.ADR/3... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HIMS & HERS HEALTH | 25,500 | -1,85 % | Hims & Hers Out with New TRT, Shares Break Even | ||
| BECTON DICKINSON | 170,55 | -1,42 % | BD (Becton, Dickinson and Company): BD Strengthens Leadership in Peripheral Vascular Innovation with Positive AGILITY Trial Results | Data through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing... ► Artikel lesen | |
| RYMAN HEALTHCARE | 0,844 | 0,00 % | Regis Healthcare vs Ryman Healthcare: Which under-the-radar ASX small-cap could double from here? | ||
| WELLBEING DIGITAL SCIENCES | 0,007 | -100,00 % | KGK Science Receives Growth Investment Led By Maxim Partners | ||
| NIAGEN BIOSCIENCE | 2,240 | +1,82 % | GetFeatured: Prime IV Hydration & Wellness Toco Hills Marks First Year in Atlanta, Highlights NAD+ IV Therapy and Niagen Options | Prime IV Hydration & Wellness (Toco Hills, GA) marks one year of serving Atlanta. The anniversary recognizes its first year of operations and highlights its NAD+ IV Therapy and Niagen(R) options. ... ► Artikel lesen | |
| SIENNA SENIOR LIVING | 12,300 | -0,81 % | Dividendenbekanntmachungen (15.10.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABBOTT LABORATORIES US0028241000 0,63 USD 0,5648 EUR ABBOTT LABORATORIES CDR CA0028221046 0,1096 CAD 0,069 EUR ABBVIE INC US00287Y1091 1... ► Artikel lesen | |
| MICROPORT SCIENTIFIC | 0,688 | -100,00 % | XFRA MSK: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILMICRP.SCIEN.REGS... ► Artikel lesen | |
| EXTENDICARE | 16,800 | 0,00 % | Extendicare declares CAD 0.0441 dividend | ||
| VERADIGM | 7,350 | -100,00 % | Veradigm Inc. - 8-K, Current Report | ||
| NATIONAL HEALTHCARE CORPORATION | 210,00 | -4,55 % | Dividendenbekanntmachungen (30.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACADIA REALTY TRUST US0042391096 0,2 USD 0,1763 EUR ADVANCED FLOWER CAPITAL INC US00109K1051 0,05 USD 0,044 EUR AGNC INVESTMENT... ► Artikel lesen | |
| UNIPHAR | 3,985 | 0,00 % | INmune Bio partners with Uniphar for Ebstrocel distribution | ||
| HANGZHOU TIGERMED CONSULTING | 4,560 | 0,00 % | TIGERMED (03347): INSIDE INFORMATION | ||
| IMMUNOVIA | 0,002 | 0,00 % | Immunovia AB: Immunovia carries out a rights issue of units of approximately SEK 63 million | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 62,36 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,450 | +1,32 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat FMC auf "Sell" mit einem Kursziel von 36 Euro belassen. Die anstehenden Quartalszahlen des Dialysespezialisten dürften angesichts der negativen... ► Artikel lesen |